Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder
Lipstein, Noa; Verhoeven-Duif, Nanda M.; Michelassi, Francesco E.; Calloway, Nathaniel; Van Hasselt, Peter M.; Pienkowska, Katarzyna; Van Haaften, Gijs; Van Haelst, Mieke M.; van Empelen, R.; Cuppen, Inge; Van Teeseling, Heleen C.; Evelein, Annemieke M V; Vorstman, Jacob A.; Thoms, Sven; Jahn, Olaf; Duran, KJ; Monroe, Glen R.; Ryan, Timothy A.; Taschenberger, Holger; Dittman, Jeremy S.; Rhee, Jeong Seop; Visser, Gepke; Jans, Judith J.; Brose, Nils
(2017) Journal of Clinical Investigation, volume 127, issue 3, pp. 1005 - 1018
(Article)
Abstract
Munc13 proteins are essential regulators of neurotransmitter release at nerve cell synapses. They mediate the priming step that renders synaptic vesicles fusion-competent, and their genetic elimination causes a complete block of synaptic transmission. Here we have described a patient displaying a disorder characterized by a dyskinetic movement disorder, developmental delay,
... read more
and autism. Using whole-exome sequencing, we have shown that this condition is associated with a rare, de novo Pro814Leu variant in the major human Munc13 paralog UNC13A (also known as Munc13-1). Electrophysiological studies in murine neuronal cultures and functional analyses in Caenorhabditis elegans revealed that the UNC13A variant causes a distinct dominant gain of function that is characterized by increased fusion propensity of synaptic vesicles, which leads to increased initial synaptic vesicle release probability and abnormal short-term synaptic plasticity. Our study underscores the critical importance of fine-tuned presynaptic control in normal brain function. Further, it adds the neuronal Munc13 proteins and the synaptic vesicle priming process that they control to the known etiological mechanisms of psychiatric and neurological synaptopathies.
show less
Download/Full Text
The full text of this publication is not available.
Keywords: General Medicine, Journal Article
ISSN: 0021-9738
Publisher: The American Society for Clinical Investigation
Note: Funding Information: Acknowledgments We are extremely grateful for the contribution of the patient's family to this study. We thank Christian Rosenmund (Berlin, Germany) for the gift of a viral expression vector; Fritz Benseler, the AGCT laboratory, Anja Günther, and Astrid Zeuch (Göttingen, Germany) for excellent technical support; Edwin Cuppen for facilitating WES; Marjolein van Susante and Karlijn Daniels-Steggehuis for psychological assessments; and the staff of the Max Planck Institute of Experimental Medicine Animal Facility (Göttingen, Germany) for mouse husbandry. This work was supported by the Max Planck Society (Munich, Germany; to NB), the European Research Council (Brussels, Belgium; ERC-ADG SYNPRIME to NB), the German Research Foundation (Bonn, Germany; CNMPB FZT103 to NB), and the NIH (NIH/NIGMS R01GM095674 to JSD, T32GM007739 to FEM).
(Peer reviewed)